Sclerostin Antibody-Induced Changes in Bone Mass Are Site Specific in Developing Crania.

Abstract

Sclerostin antibody (Scl-Ab) is an anabolic bone agent that has been shown to increase bone mass in clinical trials of adult diseases of low bone mass, such as osteoporosis and osteogenesis imperfecta (OI). Its use to decrease bone fragility in pediatric OI has shown efficacy in several growing mouse models, suggesting translational potential to pediatric disorders of low bone mass. However, the effects of pharmacologic inhibition of sclerostin during periods of rapid growth and development have not yet been described with respect to the cranium, where lifelong deficiency of functioning sclerostin leads to patterns of excessive bone growth, cranial compression, and facial palsy. In the present study, we undertook dimensional and volumetric measurements in the skulls of growing Brtl/+ OI mice treated with Scl-Ab to examine whether therapy-induced phenotypic changes were similar to those observed clinically in patients with sclerosteosis or Van Buchem disorder. Mice treated between 3 and 14 weeks of age with high doses of Scl-Ab show significant calvarial thickening capable of rescuing OI-induced deficiencies in skull thickness. Other changes in cranial morphology, such as lengths and distances between anatomic landmarks, intracranial volume, and suture interdigitation, showed minimal effects of Scl-Ab when compared with growth-induced differences over the treatment duration. Treatment-induced narrowing of foramina was limited to sites of vascular but not neural passage, suggesting patterns of local regulation. Together, these findings reveal a site specificity of Scl-Ab action in the calvaria with no measurable cranial nerve impingement or brainstem compression. This differentiation from the observed outcomes of lifelong sclerostin deficiency complements reports of Scl-Ab treatment efficacy at other skeletal sites with the prospect of minimal cranial secondary complications. © 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

• Authors: Amanda L Scheiber, David K Barton, Basma M Khoury, Joan C Marini, Donald L Swiderski, Michelle S Caird, Kenneth M Kozloff
• Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (J Bone Miner Res) Vol. 34 Issue 12 Pg. 2301-2310 (12 2019) ISSN: 1523-4681 [Electronic] United States
• PMID: 31441963 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: © 2019 American Society for Bone and Mineral Research.

Chemical References

• Adaptor Proteins, Signal Transducing
• Antibodies
• Sost protein, mouse

Topics

• Adaptor Proteins, Signal Transducing (immunology)
• Anatomic Landmarks
• Animals
• Antibodies (physiology)
• Behavior, Animal (drug effects)
• Cranial Sutures (drug effects)
• Genotype
• Male
• Organ Size
• Skull (anatomy & histology, diagnostic imaging, growth & development)
• X-Ray Microtomography